“…Since its inception, the iPSC technology has offered an almost unlimited access to in vitro models of human brain cells that are otherwise difficult to obtain from primary human brain tissue (Takahashi et al, 2007;Yu et al, 2007;Shi et al, 2017;Li et al, 2018;Li and Shi, 2020;Tong et al, 2021). Various protocols to differentiate macrophage-and microglia-like cells (iMGs) from iPSCs have been developed (Abud et al, 2017;Lee et al, 2018;McQuade et al, 2018;Pocock and Piers, 2018;Hasselmann and Blurton-Jones, 2020;Tang et al, 2022;Washer et al, 2022). Notably, iPSC differentiation into iMGs entails mesodermal specification and transition of the differentiating cells through an erythromyeloid-like progenitor, reminiscent of primitive hematopoiesis (Buchrieser et al, 2017;Lee et al, 2018).…”